The Ministry of Interior’s Medical Services, through Security Forces Hospital in Riyadh, has carried out the first robot-assisted breast reconstruction in Saudi Arabia. The patient is a 43-year-old woman who had already undergone a nipple- and skin-sparing mastectomy after a breast cancer diagnosis. The hospital reports that the operation was successful.

How did it work?

The technique belongs to the family of procedures that rebuild the breast with the patient’s own tissue. Surgeons took skin and fat from the abdomen and moved it to the chest using microsurgery, which means joining tiny blood vessels under magnification so the transferred tissue stays alive.

Done conventionally, this is demanding work. It calls for a specialized team and careful planning. The difference here is in how the tissue was harvested. The robotic system let the team work through very small incisions and preserve the integrity of the abdominal wall.

That matters because the abdominal wall is where conventional harvesting tends to cause trouble. Larger incisions raise the risk of hernias and abdominal bulging. A minimally invasive approach cuts that risk, and the hospital says it also improves surgical precision.

Why does it matter?

Reconstruction is not cosmetic polish. For women who have lost a breast to cancer, it affects quality of life, psychological well-being and self-confidence. Those outcomes shape how well a patient recovers, not just how she feels about the result.

So any method that reduces the physical price of reconstruction is worth attention. A patient who avoids a weakened abdominal wall has one fewer long-term problem to manage. That is the practical promise of this approach, though the hospital has so far reported a single case, and larger series will be needed to show how consistently the benefit holds.

The context

Breast cancer is a major concern across the GCC, and it is often diagnosed in younger women than in many Western countries. Surgical care that goes beyond removing the tumor is becoming a more visible part of cancer services in the region.

This operation also fits the direction set by Saudi Vision 2030 and the Health Sector Transformation Program, which push for higher-quality specialized care and wider adoption of advanced technology inside the Kingdom. Robotic surgery is already established in urology and general surgery in the Gulf. Moving it into microsurgical reconstruction is a more delicate test of skill and training.

The Ministry of Interior’s Medical Services describes the case as part of its wider effort to adopt the latest surgical innovations and raise the quality of care for beneficiaries. The next questions are practical ones. How many patients will be eligible, how many surgeons will be trained, and whether other major centers in Saudi Arabia and the wider Gulf will follow. If the early result holds, regional breast cancer programs will have a strong reason to invest in the same capability.

The post Saudi surgeons rebuild a breast through tiny incisions, and spare the abdominal wall appeared first on DH Arab.

HRH Prince Sultan bin Salman bin Abdulaziz, Chairman of the Board of Trustees of the King Salman Center for Disability Research, and Vice Minister of Health Eng. Abdulaziz bin Hamad Al-Rumaih signed a memorandum of understanding (MoU) to strengthen research, development and innovation (R&D&I). The partner on the health side is the National Institute for Health Research.

What’s the news?

The MoU is a framework for cooperation, not a single funded project. It sets out several areas of work:

• Supporting research excellence by encouraging national healthcare talent to take part in scientific research, through awards and research initiatives
• Developing joint research and innovation projects
• Exchanging data and expertise between the two bodies
• Expanding education and training
• Using technology and infrastructure to build innovative healthcare solutions

No budget, timeline or specific projects were announced. So the real test will be which initiatives come first and how quickly they start.

Why does it matter?

Disability research often sits apart from mainstream clinical research. Different funders, different institutions, and little shared data. This agreement tries to close that gap by putting a dedicated research centre and the national health research body under one working arrangement.

The focus on people is also worth watching. Awards and research initiatives for Saudi healthcare professionals could widen the pool of clinicians who do research, not just treat patients. That matters for a system that wants home-grown evidence rather than reliance on studies from other populations.

Data exchange is the other big piece. Shared data and expertise can raise the quality of studies and cut duplicated effort. But it also raises questions about governance and privacy, which both partners will need to handle carefully.

The context

The agreement follows national efforts to bring research and healthcare closer together. It is framed around Saudi Vision 2030, which calls for a vibrant society and a thriving economy powered by knowledge and innovation. Health research is a clear part of that plan, and the Kingdom has been building institutions to support it.

The same pattern is visible across the GCC. The UAE, Qatar and others are building research funding bodies, genomic programmes and digital health systems, and they increasingly link them to public health goals. Disability and quality of life are moving up that agenda as populations age and chronic conditions grow.

The stated aims are to build strategic partnerships that invest in knowledge, advance healthcare solutions, and raise R&D efficiency. The long-term goal is a healthier society with a sustainable quality of life. Those are broad targets, and the MoU alone will not meet them.

Still, the direction is sensible. If the two bodies publish joint projects, open up training and share data responsibly, this could become a model for other Gulf states. If not, it will join the long list of agreements signed with good intentions. Regional health leaders should watch the first announced projects closely.

The post Saudi Arabia ties disability research to its national health research push appeared first on DH Arab.

The team was led by Dr. Suha Kaaki, Consultant in Thoracic and Esophageal Surgery. She repaired the patient’s hiatal hernia and reconstructed the gastroesophageal valve, the muscular gate that keeps stomach acid out of the esophagus. The operation was coordinated between KSUMC and the Virtual Health Hospital.

How does it work?

The surgeon sits at a console and controls robotic instruments that operate on the patient in another location. The surgeon doesn’t need to be in the same medical city, or even the same facility, as the patient. A secure connection carries her movements to the robot, which carries them out inside the body.

In this case the goal was precise. Repairing the hernia returns the stomach to its proper position below the diaphragm. Rebuilding the valve restores its normal function. Together, the two steps are meant to end the reflux at its source rather than manage the symptoms with daily medication.

The program began with sixteen operations across general surgery, obstetrics and gynecology, bariatric, colorectal and thoracic procedures. The seventeenth adds to that range, and it shows the model is not limited to a single specialty.

Why does it matter?

Chronic reflux is easy to dismiss and hard to live with. Left untreated, it erodes quality of life and can lead to complications. The surgery that fixes it properly requires skill that is concentrated in a handful of major centers.

Remote robotics breaks that concentration. Patients in distant regions of the Kingdom, and beyond it, can reach rare expertise without traveling to Riyadh or waiting for a specialist to relocate. For health systems across the GCC, where populations are spread over large territories, that is a practical answer to an old access problem.

And the number matters. Seventeen operations is not a pilot stunt. KSUMC describes the program as efficient and sustainable, and a steady run of cases across several specialties supports that claim.

The context

This fits squarely inside Saudi Vision 2030 and its push to digitize healthcare and widen access to it. The Virtual Health Hospital, a Ministry of Health initiative, is a central part of that effort, linking expertise in one place to patients in another.

The same ambition is visible elsewhere in the Gulf. The UAE has made digital health and AI-supported care national priorities, and regional governments increasingly see advanced surgery as a service to export, not just to host. KSUMC leadership says it intends to keep expanding the program and strengthen the Kingdom’s position as a regional surgical hub.

Challenges remain. Reliable connectivity, clear safety protocols, training and cost will decide how far the model can spread. But the direction is clear. In Saudi Arabia, the surgeon’s location is becoming less important than the surgeon’s skill.

The post A reflux operation performed from a distance shows where Saudi surgery is heading appeared first on DH Arab.

The operation took place at the Prince Naif Center for Medical Excellence and Innovation in Riyadh. A specialized team from the Ministry of Interior’s Medical Services carried it out, and the Saudi Press Agency reported it on October 14, 2026 as the Kingdom’s first minimally invasive robot-assisted lumbar spine surgery.

How did it work?

The team used the ExcelsiusGPS robotic surgical system. It pairs surgical navigation with a robotic arm. Surgeons plan the procedure in advance, then use the arm to guide their instruments precisely during the operation.

That precision is what allows the minimally invasive approach. Smaller access points and better guidance mean less harm to the muscles and tissues around the spine. Less harm usually means less pain and a quicker return to movement, which fits with what this patient experienced.

The system does not replace the surgeon. The surgeon still plans, decides and operates. The robot keeps the instruments on the intended path.

Why does it matter?

Lumbar degeneration is common, and it affects working-age adults and older patients alike. Patients who face open spinal surgery often worry about the risks and the long rehabilitation. A technique that gets someone walking within an hour changes that conversation.

It also matters for hospital capacity. Faster mobilization can shorten stays and free up beds, a practical gain for any health system managing growing demand for specialized care.

And there is the matter of skills. The center says it intends to draw on national expertise and international experience to improve surgical practice and transfer knowledge. If that happens, the benefit reaches well beyond one patient, because trained surgeons carry the technique into other hospitals.

The context

This milestone fits the direction of Saudi Vision 2030, where health sector transformation depends on advanced technology, local expertise and better quality of specialized care. Keeping complex procedures inside the Kingdom, rather than sending patients abroad, is part of that aim.

The Ministry of Interior’s Medical Services program operates medical cities, and Prince Naif Center is described as one of its first milestones in this area. So this is an early step, not a finished program.

The wider Gulf picture is similar. The UAE and other GCC states have been investing in robotic surgery and digital health tools, and competition for regional medical excellence is real. Patients across the region increasingly expect world-class spinal care close to home.

Still, one successful case is a beginning. The real test will be volume, outcomes over time and how quickly other surgeons are trained. If the center publishes results and shares its methods, this first operation could become the start of a routine service rather than a single headline.

The post Saudi surgeons use a robot to fix a degenerated spine, and the patient walks within the hour appeared first on DH Arab.

What’s the news?

The ninth edition of the Global Health Exhibition is scheduled to take place at the Riyadh Exhibition and Convention Center, known as Malham, from 26 to 29 October 2026. Organized under the patronage of the Ministry of Health, the event carries the theme “Invest in Health” and is expected to bring together investors, researchers, policymakers, and health sector leaders from across the world.

The announcement follows a strong showing at the eighth edition, where signed agreements exceeded SAR 133 billion. The event hosted 2,200 brands, featured 600 global health leaders as speakers, and welcomed more than 130,000 visitors. International attendance rose by 54% compared to prior editions, a sign that global interest in Saudi Arabia’s health sector is not simply diplomatic rhetoric but is translating into real commercial engagement.

Why does it matter?

The numbers from last year’s edition are hard to ignore. A sixfold increase in private-sector deals is not incremental progress. It reflects a shift in how international investors and health companies are positioning themselves relative to the Kingdom’s market. Saudi Arabia has moved from being a buyer of health services to becoming a destination for health investment, research partnerships, and technology deployment.

The 2026 edition is expected to build on that momentum. Organizers describe the event as a platform designed to attract high-potential investments, support strategic partnerships, and showcase technologies shaping the future of healthcare delivery. The Ministry of Health is already inviting professionals and stakeholders to register their participation ahead of the event.

The context

The Global Health Exhibition sits firmly within the Health Sector Transformation Program, one of the core pillars of Saudi Vision 2030. The program’s goals are clear: reduce dependence on oil revenue by building a productive private health sector, improve the quality and accessibility of care for Saudi citizens, and position the Kingdom as a regional center for medical research and innovation.

Progress on those goals has been visible. Private health insurance penetration is rising. Hospital privatization has accelerated. And international health companies, from diagnostics firms to digital health platforms, are establishing a local presence in Riyadh and Jeddah at a pace that would have been unusual five years ago.

The GCC context matters here too. The UAE has its own health investment ambitions, and Qatar continues to develop its national health strategy. But Saudi Arabia’s scale, its young population, and the sheer volume of capital flowing through Vision 2030 give Riyadh a structural advantage in attracting the kind of long-term health investment that drives system-wide change. The Global Health Exhibition has become one of the clearest annual indicators of how that advantage is being used.

Professionals and organizations interested in participating in the ninth edition can register directly through the official Global Health Exhibition website.

The post Saudi Arabia’s Global Health Exhibition returns in 2026 with record ambitions appeared first on DH Arab.

Right now, that information sits across multiple systems. Clinicians often cannot access the full picture at the point of care, and researchers face delays in translating data into discovery. This collaboration, if formalised, would use Oracle’s cloud infrastructure, connected data platform, and AI capabilities to close that gap. The initiative also directly supports the healthcare transformation targets set out under Saudi Vision 2030, which has made the Kingdom’s position as a global health innovation hub a stated national priority.

How will it work?

The two organisations are exploring four areas of collaboration:

• Connecting data across the healthcare ecosystem to strengthen care coordination
• Advancing personalised medicine by drawing on clinical, genomic, and research insights to tailor prevention, diagnosis, and treatment
• Applying responsible AI to give clinicians relevant, timely information at the point of care
• Accelerating biomedical discovery to bring new research findings into patient care faster

Oracle’s secure cloud infrastructure would sit at the centre of this effort, providing the architecture needed to bring previously siloed information together. The intended result is a system where care teams receive the right insights at the right moment, and researchers can move from raw data to actionable findings more quickly.

Why does it matter?

KFSH is ranked first in the Middle East and Africa and 12th globally among the world’s top 250 academic medical centres for 2026. It also holds the title of most valuable healthcare brand in Saudi Arabia and the Middle East, according to Brand Finance, and appears on Newsweek’s lists of the World’s Best Hospitals, World’s Best Smart Hospitals, and World’s Best Specialized Hospitals for 2026. So when KFSH signals a strategic direction, the regional health sector tends to follow.

The broader significance here is the combination of genomic data and clinical records within a single AI-enabled platform. Personalised medicine has long been discussed in the GCC as a future aspiration. A working model at this scale, anchored by one of the region’s most credible institutions, would move that conversation considerably further forward.

The context

Saudi Arabia has invested heavily in digital health infrastructure over the past several years, and Vision 2030’s Health Sector Transformation Program has set targets around preventive care, hospital efficiency, and research capacity. But the challenge across the region, and indeed globally, has always been integration. Data exists. The problem is that it rarely talks to itself.

This is also part of a wider pattern of Gulf health institutions forming technology partnerships with major US cloud and AI companies. The KFSH-Oracle announcement reflects a maturing approach, one that moves beyond electronic records and toward genuinely intelligent, data-connected care. Whether the collaboration produces results at the scale it promises will depend on execution. But the direction is clear, and the institutional weight behind it is real.

The post KFSH and Oracle Health to build a unified clinical and genomic data ecosystem in Saudi Arabia appeared first on DH Arab.

What’s the news?

KPMG selected SDM from a field of ten finalists at the Saudi edition of its annual competition, which was held for the sixth time this year. The judging panel assessed companies across several criteria:

• Strength and originality of the technology
• Market potential and customer traction
• Long-term growth potential
• Quality of the pitch

SDM develops AI-driven diagnostic tools, with a particular focus on retinal imaging technology designed to support early detection of chronic and systemic diseases. The other finalists included Authena, Carevision, Eyego, LinusBio, Nommas, Plantafarm, Terraxy, Think AI, and WhiteHelmet, spanning sectors from agriculture and food supply chains to construction and space technology.

Why does it matter?

SDM’s win is more than a competition result. It points to something broader happening in Saudi Arabia’s technology sector. Naif AlObaidallah, CEO of SDM, was direct about the significance: “What we have built was born in Saudi Arabia, developed by Saudi talent, and designed for the healthcare needs of our people.” That framing matters. Saudi Arabia has spent years positioning itself as a consumer and importer of global technology. The push now, embedded in Vision 2030, is to become a producer and exporter of it.

Samer Abdallah, Partner and Board Member at KPMG in the Middle East and chair of the judging panel, said SDM stood out for combining a credible technology proposition with clear real-world application and the ability to scale. In health-tech, that combination is harder to achieve than it sounds. Many AI diagnostic tools struggle to move from pilot to clinical adoption. SDM’s traction with customers was clearly part of what convinced the panel.

The context

The KPMG Global Tech Innovator competition runs across more than 20 countries, with national winners competing at a single global final. It gives early and growth-stage technology companies exposure to KPMG’s advisory networks, access to investors, and a platform that most startups would otherwise take years to reach.

For the Gulf health-tech sector, moments like this carry real weight. The UAE has its own aggressive digital health agenda, and Saudi Arabia’s Vision 2030 has made health system modernisation a stated national priority. AI-assisted diagnostics, particularly tools that can support detection of conditions like diabetes and cardiovascular disease, which carry a significant disease burden across the GCC, are exactly the kind of home-grown solutions policymakers have been calling for.

So when SDM takes the stage in Lisbon in November, it will carry more than a competition title. It will carry a case study in what Saudi deep tech can look like when the conditions are right.

The post Saudi health-tech firm SDM wins KPMG’s 2026 Global Tech Innovator competition appeared first on DH Arab.

What’s the news?

GHE has confirmed its speaker lineup for the 2026 edition, taking place from October 26 to 29 at Riyadh Exhibition and Convention Center in Malham. More than 500 global speakers will appear across four dedicated conference stages, covering healthcare leadership, clinical innovation, digital health, and investment.

The Leaders’ Summit will bring together senior executives and policymakers to discuss how health systems can drive economic growth, integrate AI, and shift from reactive treatment toward prevention and long-term wellbeing. Speakers include GE HealthCare Chief Commercial and Growth Officer Catherine Estrampes and GSK Chair Jonathan Symonds.

The MEDX Forum will focus on translating clinical research into patient care, from advanced therapies to predictive diagnostics. Professor Declan O’Regan, who holds the British Heart Foundation Chair of Cardiovascular AI at Imperial College London, will appear alongside Dr. Samuel Sia from Columbia University. The Digital Health Forum features Professor Shafi Ahmed of Barts Health NHS Trust and Dr. Tamara Sunbul, Group CIO at Fakeeh Care Group and Co-Chair of the Global Digital Health Partnership’s Evidence and Evaluation Workstream. The Capital Xchange Forum addresses investment strategy, with speakers from SoftBank Vision Fund, Blackstone, and Mayo Clinic’s corporate development team.

New additions for 2026 include:

• Leaders’ Club, an exclusive network for senior healthcare decision-makers
• Pulse Studio, a live podcast recording space
• HealthTech Live, for live technology demonstrations
• Power Breakfast Series, focused sessions on capital, policy, and priorities
• Reverse Pitching, where corporations present strategic needs directly to startups
• Unplugged Lounge, informal networking space outside the main program

Why does it matter?

The speaker list alone tells you something. When SoftBank, Blackstone, and Mayo Clinic send senior figures to a healthcare conference in Riyadh, it reflects a genuine commercial interest, not just diplomatic goodwill. Saudi Arabia is moving capital into healthcare at scale, and international investors are paying attention.

Rachel Sturgess, Executive Vice President at Tahaluf, put it plainly: “The caliber of leaders coming to Riyadh to be part of that conversation reflects the scale of the opportunity here.” That’s a fair read. GHE is not just a venue for ideas. It’s a place where deals get framed, partnerships get started, and market entry strategies get tested against real decision-makers.

The context

Saudi Arabia’s Vision 2030 has set an explicit goal of reducing the country’s dependence on oil revenue, and healthcare is one of the sectors carrying real weight in that strategy. The Kingdom is investing heavily in hospital infrastructure, digital health systems, and biomedical research capacity. The government wants to attract foreign direct investment, build local clinical expertise, and shift public health outcomes from treatment to prevention.

GHE sits directly inside that agenda. It is organized by Tahaluf, a joint venture between Informa Markets and the Saudi Federation for Cybersecurity, Programming and Drones, which gives it both commercial credibility and institutional backing. Foundation Partners Dallah Health and Hayat National Hospital reflect the domestic health sector’s engagement, while international partners including Novartis, Stryker, Johnson and Johnson, and Canon Medical Systems signal that global industry sees Saudi Arabia as a priority market, not an afterthought.

So the question for healthcare professionals and business leaders attending is not whether Saudi Arabia is a serious player in the regional health economy. It clearly is. The more interesting question is how quickly the country can translate this level of international engagement into measurable improvements in patient outcomes, and GHE 2026 is where some of those answers will start to take shape.

The post Global Health Exhibition 2026 brings 500 speakers to Riyadh for its biggest edition yet appeared first on DH Arab.

The Saudi Food and Drug Authority (SFDA) has granted marketing authorization to two AI-enabled medical software products: “Dental IQ,” designed to support dental diagnosis, and “SAARIA,” built for retinal screening in diabetic patients. Both were developed by Saudi startups and both went through the SFDA’s Innovative Medical Devices Pathway, which offers early regulatory guidance to companies bringing novel technologies to market. Local clinical studies were conducted in the Kingdom to validate performance under real-world conditions, and both companies have committed to post-marketing follow-up to monitor how the tools perform in practice.

How does it work?

Dental IQ uses deep learning algorithms to analyze dental X-ray images. It flags potential findings such as dental caries, periodontal disease, and structural changes in teeth and surrounding tissues. The aim is to give practitioners a more consistent second read, supporting diagnostic accuracy and treatment planning.

SAARIA analyzes retinal fundus images using AI to screen diabetic patients for signs of diabetic retinopathy. Early detection is the core objective. The software is designed to identify patients who may need specialist evaluation, helping to speed up referral before the condition progresses. Diabetic retinopathy remains one of the leading causes of preventable blindness globally, and in the GCC, where diabetes prevalence is among the highest in the world, the clinical need is acute.

Both products are positioned as clinical support tools, not autonomous decision-makers. The SFDA has been clear on this point: AI outputs are intended to inform clinical judgment, not replace it. Healthcare professionals retain full responsibility for reviewing findings and making decisions based on each patient’s condition.

Why does it matter?

The GCC has no shortage of imported health technology. What it has historically lacked is domestically built, domestically validated medical software. These two approvals change that, at least in part. They show that local companies can produce AI tools that meet regulatory standards, conduct rigorous clinical studies, and bring a product to market through formal channels.

There are also practical benefits specific to the region. AI models trained and validated on local patient populations, with the demographic and epidemiological characteristics of Saudi Arabia, are more likely to perform reliably in Saudi clinical settings than tools developed elsewhere. That matters especially for diabetic retinopathy screening, where early, accurate detection can prevent blindness in a high-risk population.

The context

These approvals sit within a broader policy push. Saudi Arabia’s Health Sector Transformation Program, one of the pillars of Vision 2030, has set explicit targets around digital health adoption, local industry development, and improved patient outcomes. Regulatory bodies like the SFDA have a direct role in that agenda, and the Innovative Medical Devices Pathway was built precisely to support companies that might otherwise struggle with the time and complexity of standard regulatory processes.

Across the GCC, regulators are working to build frameworks that can keep pace with AI in healthcare without sacrificing safety. The UAE has its own digital health strategy and the Dubai Health Authority has been active in piloting AI clinical tools. But approvals of locally developed AI medical software, validated through domestic clinical studies, are still relatively rare in the region. Saudi Arabia has now set a reference point. Other GCC markets will be watching.

The post Saudi Arabia clears its first homegrown AI diagnostic tools for dentistry and eye disease appeared first on DH Arab.

King’s Jeddah opened in 2025 as an extension of King’s College Hospital London, a teaching institution founded in 1840. It operates under the same UK clinical protocols as its London counterpart and has over 130 specialist consultants across 35 clinical specialties and 10 centres of excellence. That’s a significant clinical footprint, and it demands a digital infrastructure to match.

The hospital has been running InterSystems TrakCare as its core EHR since opening. The move to IntelliCare is not a switch from a failing system. It’s a progression from one that worked. That distinction matters. The clinical and operational teams already understand the InterSystems environment, which means the transition carries less disruption risk and more institutional confidence behind it.

Dr. Ibrahim Alharfi, Chief Executive Officer of King’s College Hospital London – Jeddah, put it plainly: “Technology is not the destination; better patient outcomes are. Adopting InterSystems IntelliCare enables our teams to work with greater intelligence, reduce avoidable delays, and keep the clinician’s attention where it belongs: on the patient in front of them.”

How will it work?

IntelliCare is built on the TrakCare foundation but designed to embed AI directly into clinical workflows rather than sitting alongside them. For King’s Jeddah, the platform will introduce several key capabilities:

• Ambient clinical documentation: AI listens to clinical conversations and converts them into structured records automatically, cutting the time clinicians spend typing.
• Built-in AI workflow intelligence: Intelligence is present at every step, from ordering and prescribing to reviewing results, without requiring separate integrations.
• Clinician-centred design: The system is built to minimise the friction technology creates during patient encounters.
• Enhanced interoperability: Full support for HL7 FHIR and SMART on FHIR standards, connecting the hospital within Saudi Arabia’s broader health data ecosystem.

Diaa Kamal, Chief Information Officer at King’s Jeddah, described the platform as one where “AI surfaces the right information at the right moment, documentation happens naturally, and workflows adapt to the clinician rather than the other way around.”

Why does it matter?

The EMEA-first status is notable, but the more significant point is what this reflects about Saudi Arabia’s trajectory in healthcare technology. The Kingdom’s Vision 2030 health agenda has consistently pushed institutions to raise care quality while reducing inefficiencies. AI-embedded clinical systems are a direct answer to both goals.

Ambient documentation alone addresses one of the most persistent complaints from clinicians globally: that they spend more time with screens than with patients. If IntelliCare delivers on that promise at King’s Jeddah, it will carry weight far beyond one hospital’s deployment.

Ali Abi Raad, Managing Director of InterSystems Middle East, India and South Africa, said King’s Jeddah is “perfectly positioned to realise the full potential of IntelliCare,” pointing to the hospital’s existing foundation on TrakCare as the basis for that confidence.

The context

Saudi Arabia has invested heavily in health digitisation over the past several years, with the Ministry of Health pushing EHR adoption across public and private sectors alike. But the conversation is shifting. Basic digitisation is largely done. The question now is what healthcare institutions do with the data they are collecting and how intelligently their systems can act on it.

King’s Jeddah’s decision to adopt an AI-native EHR places it at the front of that conversation in the region. And because it sits within a globally recognised clinical brand, with strong academic oversight and measurable outcome standards, what happens there will be watched closely by peers across the GCC. This is the kind of deployment that tends to set direction for others.

The post King’s College Hospital Jeddah to become first hospital in EMEA to run InterSystems IntelliCare appeared first on DH Arab.